PharmacyCodes



Adinazolamum [Inn-Latin] en es it fr

Adinazolamum [Inn-Latin] Brand names, Adinazolamum [Inn-Latin] Analogs

Adinazolamum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Adinazolamum [Inn-Latin] Chemical_Formula

C19H18ClN5

Adinazolamum [Inn-Latin] RX_link

No information avaliable

Adinazolamum [Inn-Latin] fda sheet

Adinazolamum [Inn-Latin] msds (material safety sheet)

Adinazolamum [Inn-Latin] Synthesis Reference

No information avaliable

Adinazolamum [Inn-Latin] Molecular Weight

351.833 g/mol

Adinazolamum [Inn-Latin] Melting Point

No information avaliable

Adinazolamum [Inn-Latin] H2O Solubility

No information avaliable

Adinazolamum [Inn-Latin] State

Solid

Adinazolamum [Inn-Latin] LogP

4.05

Adinazolamum [Inn-Latin] Dosage Forms

No information avaliable

Adinazolamum [Inn-Latin] Indication

For treatment of panic disorder

Adinazolamum [Inn-Latin] Pharmacology

Adinazolam is a benzodiazepine derivative used to treat anxiety, status epilepticus, and for sedation induction and anterograde amnesia. Adinazolam binds with high affinity to the GABA benzodiazepine receptor complex. Considerable evidence suggest that the central pharmacologic/therapeutic actions of alprazolam are mediated via interaction with this receptor complex.

Adinazolamum [Inn-Latin] Absorption

No information avaliable

Adinazolamum [Inn-Latin] side effects and Toxicity

Signs of overdose may include muscle weakness, ataxia, dysarthria and particularly in children paradoxical excitement. In more severe cases diminished reflexes, confusion, and coma may ensue.

Adinazolamum [Inn-Latin] Patient Information

No information avaliable

Adinazolamum [Inn-Latin] Organisms Affected

Humans and other mammals